Caj Westlund 2024-08-23 Caj Westlund 2024-08-23

Stockholm3 independently validated at the world-renowned Martini Klinik

Läs mer

Caj Westlund 2024-07-24 Caj Westlund 2024-07-24

Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology

Läs mer

Caj Westlund 2024-07-03 Caj Westlund 2024-07-03

Stockholm 3 commercially available in the USA

Läs mer

Caj Westlund 2024-06-26 Caj Westlund 2024-06-26

Stockholm3 reduces prostate cancer treatment costs and enhances diagnostic precision

Läs mer

Caj Westlund 2024-05-31 Caj Westlund 2024-05-31

Leadership changes at A3P Biomedical

Läs mer

Caj Westlund 2024-04-22 Caj Westlund 2024-04-22

Stockholm3 study awarded best abstract in the prostate cancer biopsy indication session at the 2024 European Association of Urology meeting

Läs mer

Caj Westlund 2024-02-20 Caj Westlund 2024-02-20

Stockholm3 evaluated for Swedish screening program

Läs mer

Caj Westlund 2024-02-13 Caj Westlund 2024-02-13

Stockholm3 leads to earlier detection of prostate cancer, improved precision, and better health economics

Läs mer

Caj Westlund 2024-01-29 Caj Westlund 2024-01-29

Landmark Stockholm3 North American clinical trial presented at ASCO-GU

Läs mer

Caj Westlund 2023-09-13 Caj Westlund 2023-09-13

A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA

Läs mer